Am J Cardiol 2004,
PMID: 15541252
Merino, Alvaro; Gayá, Antonio; Segura, Ignacio; Calvo, Javier; Imízcoz, Cristina; Berenguel, Alejandro; Alegría, Eduardo
C-reactive protein (CRP), interleukin-6 (IL-6), and the -174 GC IL-6 gene polymorphism were analyzed after coronary angioplasty in 50 patients, 25 of whom were treated with the glycoprotein IIb/IIIa platelet receptor inhibitor eptifibatide for 24 hours. It was found that glycoprotein IIb/IIIa inhibition significantly blocked postangioplasty CRP increases in all patients but blocked IL-6 increases only in patients carrying the -174 GG genotype.
Diseases/Pathways annotated by Medline MESH: Coronary Disease
Document information provided by NCBI PubMed
Text Mining Data
CRP → glycoprotein: "
It was found that
glycoprotein IIb/IIIa inhibition significantly
blocked postangioplasty
CRP increases in all patients but blocked IL-6 increases only in patients carrying the -174 GG genotype
"
IL-6 → glycoprotein: "
It was found that glycoprotein IIb/IIIa inhibition significantly blocked postangioplasty CRP increases in all patients but blocked IL-6 increases only in patients carrying the -174 GG genotype
"
Manually curated Databases
No curated data.